Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Depreciation & Amortization (CF) (2023 - 2025)

Contineum Therapeutics has reported Depreciation & Amortization (CF) over the past 3 years, most recently at $62000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $62000.0 for Q4 2025, down 17.33% from a year ago — trailing twelve months through Dec 2025 was $300000.0 (up 16.28% YoY), and the annual figure for FY2025 was $300000.0, up 16.28%.
  • Depreciation & Amortization (CF) for Q4 2025 was $62000.0 at Contineum Therapeutics, down from $81000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for CTNM hit a ceiling of $81000.0 in Q3 2025 and a floor of $42000.0 in Q2 2023.
  • Median Depreciation & Amortization (CF) over the past 3 years was $62000.0 (2024), compared with a mean of $63166.7.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 78.57% in 2024 and later dropped 17.33% in 2025.
  • Contineum Therapeutics' Depreciation & Amortization (CF) stood at $42000.0 in 2023, then surged by 78.57% to $75000.0 in 2024, then dropped by 17.33% to $62000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $62000.0 (Q4 2025), $81000.0 (Q3 2025), and $79000.0 (Q2 2025) per Business Quant data.